Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.

Production records written using erasable markers, use of expired raw materials, and more.

Day 3 closes out with sessions on drug delivery devices

Looking for a guide to day 2 of the show? We’ve got you covered.

Lonza’s Enprotect Capsule is the recipient of The Medicine Maker 2023 Innovation Awards.

Interphex kicks off today in New York. Here’s what to look out for on day 1.

How the drive to try something new led to the development of lentiviral vectors for gene therapy.

Cardinal Health’s Fran Gregory looks at innovative payment models for cell and gene therapies.

Cardinal Health’s Fran Gregory talks about the high costs of cell and gene therapies, and what this means for payers.